Physician

An L Tran, M.D.

According to 2025 Medicare claims, An Tran, M.D. (NPI: 1366637563) practices hematology/oncology in the Cleveland, TN market, with the plurality of this provider's patient population coming from Bradley, TN. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 37311-5074.

Tran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 683 traditional Medicare patients, billed 169,970 HCPCS/CPT codes, and received $2,499,977 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,645 prescription claims across 320 beneficiaries totaling $2,721,102 in drug costs, led by Revlimid (Lenalidomide). DME data shows 11 claims. Open Payments data shows 62 records totaling $1,435. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,200,052 to $2,499,977. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $754,414 to $2,721,102. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $1,200,052 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,427,868 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,702,448 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,258,568 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,047,758 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,456,289 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,310,388 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,455,022 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,346,756 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,499,977 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015524131,757$1,200,052
2016529163,338$1,427,868
2017602156,166$1,702,448
2018663180,725$2,258,568
2019615231,122$3,047,758
2020644191,606$2,456,289
2021638184,277$2,310,388
2022654204,041$2,455,022
2023655199,311$2,346,756
2024683169,970$2,499,977

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.9M2015 Drug cost: $754,414 (USD; Tot_Drug_Cst)2016 Drug cost: $1,054,929 (USD; Tot_Drug_Cst)2017 Drug cost: $1,534,957 (USD; Tot_Drug_Cst)2018 Drug cost: $2,393,232 (USD; Tot_Drug_Cst)2019 Drug cost: $2,683,056 (USD; Tot_Drug_Cst)2020 Drug cost: $3,862,618 (USD; Tot_Drug_Cst)2021 Drug cost: $3,534,616 (USD; Tot_Drug_Cst)2022 Drug cost: $3,354,740 (USD; Tot_Drug_Cst)2023 Drug cost: $2,963,921 (USD; Tot_Drug_Cst)2024 Drug cost: $2,721,102 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015165984$754,414
20161581,212$1,054,929
20171951,592$1,534,957
20182622,044$2,393,232
20192561,811$2,683,056
20202631,715$3,862,618
20212731,811$3,534,616
20222921,535$3,354,740
20232771,589$2,963,921
20243201,645$2,721,102

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$11K$22K2015 Medicare payment: $22,154 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,711 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $8,101 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,759 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,177 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,772 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,740 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $492 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R67$22,154
2016N/RN/RN/R
2017N/R28$2,711
2018N/RN/RN/R
2019N/R62$8,101
2020N/R74$4,759
2021N/R12$1,177
2022N/R65$2,772
2023N/R24$1,740
2024N/R11$492

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more240403$86
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's188328$12
80053Blood test, comprehensive group of blood chemicals4241,270$10
36415Insertion of needle into vein for collection of blood sample5021,533$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4801,947$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide501,243$740,676
PomalystPomalidomide13364$263,732
CalquenceAcalabrutinib Maleate14420$184,479
JakafiRuxolitinib Phosphate14420$150,668
Abiraterone AcetateAbiraterone Acetate702,100$142,196

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0260Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattressYN/R11$492

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.62$1,435Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for An L. Tran, M.D.?

Tedicare shows public-source Medicare data for An L. Tran, M.D. (NPI 1366637563), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does An L. Tran, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to An L. Tran, M.D.?

An L. Tran, M.D. is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does An L. Tran, M.D. have Open Payments data?

An L. Tran, M.D. has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.